Educational Objectives
The overall goal of this program is to enhance knowledge and improve understanding of various interventional techniques and devices with management of
various cardiac disease states.
Upon completion of this program, participant should be able to:
- Compare and contrast the use of appropriate devices to facilitate stent delivery and
expansion in complex cases - Assess the plan for the best interventional strategy and adjust therapy by the data provided
during live case discussion and presentations - Apply case selection and choose the appropriate interventional devices for peripheral vascular disease
- Identify and select the appropriate techniques for treatment of structural heart disease
- Demonstrate the revascularizations/Percutaneous Coronary Interventions and CABG for patients with advanced coronary artery disease
Accreditation
The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The Mount Sinai School of Medicine designates this live activity for a maximum of 30.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credits apply to June 14-15, 2012 (Coronary Symposium and Vascular Symposium).
Verification of Attendance
Verification of attendance will be provided to all professionals.
Special Needs
The Mount Sinai School of Medicine is in full compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special
needs. If you would like to attend this conference and require any special needs or accommodations, please contact the Page and William Black Post-Graduate
School of Medicine at 212-731-7950.
Faculty Disclosure
It is the policy of MSSM to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME sponsored educational activities. All faculty
participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist
in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions
of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials.